NEW YORK, June 2 (Reuters) - Health insurer Cigna (CI.N), opens new tab will stop covering GLP-1 weight-loss drugs including Novo Nordisk's (NOVOb.CO), opens new tab Wegovy and Eli Lilly's (LLY.N), ...
Cigna’s Evernorth health is investing $100 million to support a new AI-powered program designed to improve how patients ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Employers and health plans are increasingly refusing to cover costly GLP-1 drugs like ...
Cigna's exit from ACA market follows another major, national carrier and some are concerned about continued market tightening ...
Hosted on MSN
Cigna drops coverage of GLP-1 obesity drugs for its own employees: What’s the future of weight-loss treatment
The battle over America's booming weight-loss drug market has a significant update, with a move that’s likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of ...
NEW YORK — Health insurer Cigna will stop covering GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly 's Zepbound, in its employee health plan effective July 1, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results